Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities.

Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ.

Clin Orthop Relat Res. 2014 Jan;472(1):66-72. doi: 10.1007/s11999-013-3134-0.

2.

Single perioperative dose of tranexamic acid in primary hip and knee arthroplasty.

George DA, Sarraf KM, Nwaboku H.

Eur J Orthop Surg Traumatol. 2015 Jan;25(1):129-33. doi: 10.1007/s00590-014-1457-5. Epub 2014 Apr 23.

PMID:
24756178
3.

Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.

Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ.

Clin Orthop Relat Res. 2013 Jan;471(1):150-4. doi: 10.1007/s11999-012-2488-z.

4.

Does Tranexamic Acid Reduce Blood Loss and Transfusion Requirements Associated With the Periacetabular Osteotomy?

Wingerter SA, Keith AD, Schoenecker PL, Baca GR, Clohisy JC.

Clin Orthop Relat Res. 2015 Aug;473(8):2639-43. doi: 10.1007/s11999-015-4334-6. Epub 2015 May 20.

5.

Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice.

Vigna-Taglianti F, Basso L, Rolfo P, Brambilla R, Vaccari F, Lanci G, Russo R.

Eur J Orthop Surg Traumatol. 2014 May;24(4):545-51. doi: 10.1007/s00590-013-1225-y. Epub 2013 Apr 30.

PMID:
23633085
6.

The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.

Wind TC, Barfield WR, Moskal JT.

J Arthroplasty. 2014 Feb;29(2):387-9. doi: 10.1016/j.arth.2013.05.026. Epub 2013 Jun 21.

PMID:
23790499
7.

Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.

Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS.

Clin Orthop Relat Res. 2014 May;472(5):1552-7. doi: 10.1007/s11999-013-3446-0. Epub 2014 Jan 3.

8.

One dose of tranexamic acid is safe and effective in revision knee arthroplasty.

Smit KM, Naudie DD, Ralley FE, Berta DM, Howard JL.

J Arthroplasty. 2013 Sep;28(8 Suppl):112-5. doi: 10.1016/j.arth.2013.05.036. Epub 2013 Aug 13.

PMID:
23953962
9.

Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety.

Poeran J, Rasul R, Suzuki S, Danninger T, Mazumdar M, Opperer M, Boettner F, Memtsoudis SG.

BMJ. 2014 Aug 12;349:g4829. doi: 10.1136/bmj.g4829.

10.

The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty.

Wind TC, Barfield WR, Moskal JT.

J Arthroplasty. 2013 Aug;28(7):1080-3. doi: 10.1016/j.arth.2012.11.016. Epub 2013 Mar 28.

PMID:
23541868
11.

Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis.

Gandhi R, Evans HM, Mahomed SR, Mahomed NN.

BMC Res Notes. 2013 May 7;6:184. doi: 10.1186/1756-0500-6-184.

12.

Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial.

Sa-Ngasoongsong P, Wongsak S, Chanplakorn P, Woratanarat P, Wechmongkolgorn S, Wibulpolprasert B, Mulpruek P, Kawinwonggowit V.

BMC Musculoskelet Disord. 2013 Dec 5;14:340. doi: 10.1186/1471-2474-14-340.

13.

Preliminary investigation of high-dose tranexamic acid for controlling intraoperative blood loss in patients undergoing spine correction surgery.

Xie J, Lenke LG, Li T, Si Y, Zhao Z, Wang Y, Zhang Y, Xiao J.

Spine J. 2015 Apr 1;15(4):647-54. doi: 10.1016/j.spinee.2014.11.023. Epub 2014 Nov 29.

PMID:
25457470
14.

Tranexamic acid: optimal blood loss management in surface replacement arthroplasty.

Sassoon A, Nam D, Jackups R, Johnson SR, Nunley RM, Barrack RL.

Bone Joint J. 2016 Feb;98-B(2):173-8. doi: 10.1302/0301-620X.98B2.36776.

PMID:
26850421
15.

Efficacy and safety of tranexamic acid versus ϵ-aminocaproic acid in cardiovascular surgery.

Falana O, Patel G.

Ann Pharmacother. 2014 Dec;48(12):1563-9. doi: 10.1177/1060028014549558. Epub 2014 Sep 11.

PMID:
25214649
16.

One step closer to sparing total blood loss and transfusion rate in total knee arthroplasty: a meta-analysis of different methods of tranexamic acid administration.

Shemshaki H, Nourian SM, Nourian N, Dehghani M, Mokhtari M, Mazoochian F.

Arch Orthop Trauma Surg. 2015 Apr;135(4):573-88. doi: 10.1007/s00402-015-2189-7. Epub 2015 Mar 5. Review.

PMID:
25739992
17.

Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty.

Kelley TC, Tucker KK, Adams MJ, Dalury DF.

Transfusion. 2014 Jan;54(1):26-30. doi: 10.1111/trf.12167. Epub 2013 Mar 22.

PMID:
23521109
18.

Effectiveness of tranexamic acid in revision total knee arthroplasty.

Aguilera X, Videla S, Almenara M, Fernandez JA, Gich I, Celaya F.

Acta Orthop Belg. 2012 Feb;78(1):68-74.

PMID:
22523930
19.

Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty.

Konig G, Hamlin BR, Waters JH.

J Arthroplasty. 2013 Oct;28(9):1473-6. doi: 10.1016/j.arth.2013.06.011. Epub 2013 Jul 23.

20.

Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.

Sander M, Spies CD, Martiny V, Rosenthal C, Wernecke KD, von Heymann C.

Crit Care. 2010;14(4):R148. doi: 10.1186/cc9216. Epub 2010 Aug 3.

Items per page

Supplemental Content

Write to the Help Desk